# Clinical Trails to Evaluate H5N1 Influenza Variant Vaccines

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2024 · $7,985,002

## Abstract

The current influenza H5N1 outbreak is an ongoing public health situation that has been observed in various regions throughout the US. H5N1 is a highly pathogenic avian influenza virus that primarily affects birds but can also infect other animals, including cattle (bovine H5N1). The objective of this Task Order supports NIAID’s goal to conduct phase 1 and phase 2 trials on H5N1 influenza vaccines to generate data to inform decisions on which candidates to support for advanced development.

## Key facts

- **NIH application ID:** 11210622
- **Project number:** 75N91019D00024-0-759102400032-1
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** THERESA ENGEL
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $7,985,002
- **Award type:** —
- **Project period:** 2024-09-09 → 2027-09-08

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11210622

## Citation

> US National Institutes of Health, RePORTER application 11210622, Clinical Trails to Evaluate H5N1 Influenza Variant Vaccines (75N91019D00024-0-759102400032-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11210622. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*